Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease.

Biomarkers Gene Editing Genetic Therapy Humans Pulmonary Disease, Chronic Obstructive / metabolism
CRISPR/Cas-9 biomarkers cellular therapy chronic obstructive pulmonary disease genome editing oxidative stress

Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
08 2019
Historique:
received: 17 10 2018
revised: 10 02 2019
accepted: 14 02 2019
pubmed: 27 3 2019
medline: 29 5 2020
entrez: 27 3 2019
Statut: ppublish

Résumé

Chronic obstructive pulmonary disease accounts as the leading cause of mortality worldwide prominently affected by genetic and environmental factors. The disease is characterized by persistent coughing, breathlessness airways inflammation followed by a decrease in forced expiratory volume

Identifiants

DOI: 10.1002/jcp.28482 PMID: 30912142
pubmed: 30912142
doi: 10.1002/jcp.28482
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16703-16723

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Ridhima Wadhwa (R)

Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India.
ORCID: 0000-0001-8074-1543

Taru Aggarwal (T)

Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.

Vamshikrishna Malyla (V)

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, New South Wales, Australia.
Centre for Inflammation, Centenary Institute, Sydney, New South Wales, Australia.

Nitesh Kumar (N)

Amity Institute for Advanced Research & Studies (M&D), Amity University, Noida, Uttar Pradesh, India.

Gaurav Gupta (G)

School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, India.

Dinesh Kumar Chellappan (DK)

Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Harish Dureja (H)

Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, Haryana, India.

Meenu Mehta (M)

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

Saurabh Satija (S)

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

Monica Gulati (M)

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

Pawan Kumar Maurya (PK)

Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India.

Trudi Collet (T)

Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.

Philip Michael Hansbro (PM)

Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
Centre for Inflammation, Centenary Institute, Sydney, New South Wales, Australia.
School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.

Kamal Dua (K)

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, New South Wales, Australia.
Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
Centre for Inflammation, Centenary Institute, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Identification of biomarkers and genetic...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Génie génétique › Édition de gène › Identification of biomarkers and genetic...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Génie génétique › Thérapie génétique › Identification of biomarkers and genetic...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Identification of biomarkers and genetic...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Broncho-pneumopathie chronique obstructive › Identification of biomarkers and genetic...